Clinical Practice Session
Therapeutic Controversies in AKI Recovery Care
November 04, 2023 | 02:00 PM - 04:00 PM
Location: Room 204, Pennsylvania Convention Center
Session Description
Development of AKI during a hospitalization is associated with an increased risk of CKD, CVD, frequent readmissions, and decreased quality of life among survivors. Several therapeutic interventions have been proposed to promote AKI recovery, but data in support of their impact on clinical and patient centered outcomes are variable. The session discusses the evidence behind key areas of controversy in the therapeutic approach to AKI survivors.
ASN thanks the ASN AKINow Recovery/Post-AKI Workgroup for assistance with this session.
Learning Objective(s)
- Describe the preferred BP target for AKI survivors to improve outcomes
- Formulate a recommendation for when to resume or introduce nephroprotective agents (RAS/SGLT2 inhibitors) after an episode of AKI
- Distinguish the dialysis techniques used in AKI survivors to promote recovery from those used in patients on chronic dialysis
- Critique the evidence for sick day protocols and educational interventions in AKI survivors
Learning Pathway(s)
- AKI and Critical Care
- Pharmacology
Moderators
Presentations
- Press Your Luck: Targets and Tactics to Manage BP in AKI Survivors
02:00 PM - 02:30 PM
- The Who, When, and How of RAS/SGLT2 Inhibitors in AKI Survivors
02:30 PM - 03:00 PM
- Dialysis Distinctions: AKI vs. ESKD
03:00 PM - 03:30 PM
- Under the Weather: Sick Day Protocols in AKI Survivors
03:30 PM - 04:00 PM